Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and UltraTech Cement.
Sudarshan Sukhani of s2analytics.com recommends buying Biocon and advises selling Page Industries, Dr Reddy's Labs, Vedanta and Havells India.
Ashwani Gujral of ashwanigujral.com recommends buying UltraTech Cement, Biocon and CESC and advises selling Engineers India and OBC.
Siddarth Bhamre of Angel Broking recommends buying Axis Bank and Biocon.
Prakash Gaba of prakashgaba.com is of the view that one can short SAIL and Adani Power and feels that Biocon may hit Rs 410.
Rajat Bose of rajatkbose.com is of the view that one may short Biocon and advises buying Asian Paints and Pidilite Industries.
Hemen Kapadia of KRChoksey Securities advises buying Biocon with a target of Rs 474.
Prakash Gaba of prakashgaba.com recommends going long in Hindustan Unilever and feels that one can short BHEL, Reliance Power and Biocon.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Biocon and Titan Company.
Hemen Kapadia of KRChoksey Securities advises buying Hindustan Unilever with a target of Rs 822.
Sudip Bandopadhyay, Market Expert recommends buying Infosys and is cautious on IT and advises avoiding PSU banks.
Ashish Kyal of wavesstrategy.com recommends buying Biocon and Reliance Infrastructure.
Simi Bhaumik of simibhaumik.com advises buying Biocon with a target of Rs 55.
According to Rajat Bose of rajatkbose.com, Biocon may move to Rs 556.
Prakash Gaba of prakashgaba.com feels that Dewan Housing Finance Corporation may test Rs 241.
Rahul Shah of Motilal Oswal advises buying Biocon 510 Call.
Krish Subramanyam of Altamount Capital advises buying Bliss GVS with a target of Rs 186.
Simi Bhaumik of simibhaumik.com suggests buying Biocon and Vishnu Chemicals.
Sharmila Joshi of sharmilajoshi.com advises buying Biocon with a target of Rs 489.
Experts such as Porinju Veliyath, MD & Portfolio Manager, Equity Intelligence India, SP Tulsian of sptulsian.com, market expert Ambareesh Baliga and Prakash Diwan of prakashdiwan.in have already picked 16 midcap and smallcap multibaggers for calendar year 2016
Gaurav Bissa of LKP Securities recommends buying Marico with a target of Rs 450 and Sun Pharma with a target of Rs 820.
Rakesh Bansal, Vice President at RK Global buying Apollo Hospitals Enterprises and Biocon.
Sudarshan Sukhani of s2analytics.com advises buying Biocon.
VK Sharma of HDFC Securities advises buying Biocon 460 Call.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon and hold the stock.